ACTRN12613000068763已完成3 期
Pharmacokinetics of Subcutaneous Injection (SC)of Testosterone in an Oil Vehicle: Nandrolone (ND) in Healthy Volunteers
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 55 Years(—)
- 性别
- Male
入选标准
- •*Healthy male volunteers
- •*Aged 18-55 yr
- •*Written, informed consent & willing to comply with study requirements
排除标准
- •*Contraindication to nanadrolone
- •*Seeking fertility in the next year
- •*Involved in any professional or recreational activities requiring urine drug screening
- •*History of illicit drug abuse within last year
- •*History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements
- •*Regular medications that interfere with absorption, metabolism or action of testosterone
- •* Taking medications for antiplatelet or anticoagulant therapy
研究者
相似试验
已完成
4 期
A Research Study of Injections of Testosterone in an Oil Vehicle for men with Androgen Deficiency: Reandron (Testosterone Undecanoate) will be administered subcutaneously and intramuscularly.ACTRN12613000101785Sydney Local Health District11
进行中(未招募)
不适用
Pharmacokinetics and Pharmacodynamics of subcutaneous applied insulin aspart administered with the FlexPen® insulin pen compared to inhaled insulinadministered with the Exubera® deviceEUCTR2007-002060-10-DEikfe GmbH
进行中(未招募)
1 期
Feasibility and effects of subcutaneously given combination of dexmedetomidine and ketamine in ALS patients receiving palliative careAmyotrophic lateral sclerosis (ALS)MedDRA version: 20.1Level: LLTClassification code 10036704Term: Primary lateral sclerosisSystem Organ Class: 100000004852EUCTR2018-000142-18-FITurku University Hospital20
已完成
4 期
Efficacy and Safety of Subcutaneous Administration of Lyophilized Powder of Alpha-Erythropoietin to Maintains Hemoglobin Concentrations among Hemodialysis PatientsAnemia associated with chronic kidney diseaseHemodialysisLyophilised powderErythropoietinAnemiaTCTR20161214001Phramongkutklao hospital and College of Medicine63
招募中
2 期
The efficacy and safety of subcutaneous injection of bortezomib combined with doxorubicin and dexamethasone for untreated multiple myeloma patients.multiple myelomaJPRN-UMIN000007803ational Hospital Organization Disaster Medical Center35
